Synovus Financial’s Immunomedics Inc IMMU Stock Holding History

Synovus Financial’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-4,600	Closed	-$62K	–	2256
2020 Q1	$62K	Buy	+4,600	New	+$77.4K	﹤0.01%	1050

Other funds holding IMMU

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Synovus Financial's IMMU Position: Q2 2020 in Review

Synovus Financial sold out of Immunomedics Inc (IMMU) in Q2 2020, closing a stake of 4,600 shares — an estimated $62K sold.

Synovus Financial first reported a position in IMMU in Q1 2020 and held it in 1 quarter. The position peaked at $62K in Q1 2020. 313 funds tracked by Wall St. Rank hold IMMU as of Q2 2020.

Synovus Financial reported no remaining Immunomedics Inc position as of Q2 2020 after selling out during the quarter.
Synovus Financial sold 4,600 Immunomedics Inc shares in Q2 2020, an estimated $62K.
Synovus Financial first reported a position in Immunomedics Inc in Q1 2020 and held it in 1 quarter.
Synovus Financial's Immunomedics Inc position peaked at $62K in Q1 2020.
313 funds tracked by Wall St. Rank held Immunomedics Inc as of Q2 2020.

Based on Synovus Financial's 13F filing for Q2 2020, filed 10 Aug 2020.